Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VCLT✓SelectedUSD · VCLTGSK vs VCLT performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs VCLT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
VCLT return
+11.8%
Excess return
+41.0%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioVCLTExcessAlpha
1D-0.1%+0.7%-0.9%-0.6%
7D-5.3%+1.0%-6.3%-6.0%
30D-3.7%+0.7%-4.3%-4.0%
3M-7.3%-1.1%-6.1%-6.6%
6M-4.2%-2.6%-1.6%-2.6%
YTD+0.9%-3.3%+4.2%+3.1%
1Y+7.3%-3.2%+10.5%+9.6%
3Y+52.7%+10.9%+41.9%+52.5%
All+52.7%+11.8%+41.0%+52.5%

Cumulative growth

Daily Returns

Daily percentage return beside VCLT.

Daily Out/Under-Performance

Portfolio return minus VCLT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VCLT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded VCLT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling